查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1766395

STI和陰道炎的PCR檢驗市場，規模，佔有率，趨勢，產業分析報告:病理(性感染疾病，陰道炎)，檢驗類別，各最終用途，各地區，2025年～2034年的市場預測

STI and Vaginitis PCR Testing Market Size, Share, Trends, & Industry Analysis Report By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球性傳染病和陰道炎 PCR 檢測市場規模將達到 15.7843 億美元。本研究報告深入分析了當前的市場動態，並對未來市場成長進行了分析。

性傳染感染和陰道炎 PCR 檢測市場專注於利用聚合酶鍊式反應 (PCR) 技術進行先進的診斷，用於針對性傳播感染和不同類型陰道感染的病原體特異性檢測。這些感染包括常見的性傳染病 (STI)，例如披衣菌感染、淋病和滴蟲病，以及陰道感染，例如細菌性陰道炎和外陰陰道念珠菌病。 PCR檢測的獨特之處在於其高靈敏度和特異性，以及能夠準確捕捉致病細菌的遺傳物質，無論其數量多麼微量。這種高準確度對於快速且準確的診斷以及製定強有力的針對性治療計劃以應對疾病進展和避免進一步感染至關重要。

基於多種原因，人們對該領域的檢測抱持特別樂觀的期望。該地區性傳染感染和陰道炎的盛行率不斷上升，增加了對準確診斷的需求。分子診斷工具的發展以及多重PCR檢測的發展也加速了該領域的發展。從單一樣本中檢測多種病原體的能力提高了效率，並為臨床醫生提供了診斷資訊。此外，公眾意識的提高和積極的篩檢活動正在加強大規模檢測的力度，這是一個朝著明確界定性與生殖健康方向發展的令人鼓舞的趨勢。這種變化需要準確可靠的診斷工具，以便有針對性地、有策略地獲取資訊。

性傳染感染 (STI) 和陰道炎 PCR 檢測市場報告重點

按病理學分類，性傳染感染 (STI) 領域在 2024 年佔據了主要佔有率。這是由於各種性傳染感染 (STI) 的全球盛行率持續居高不下，其中許多是無症狀的，並且迫切需要 PCR 等準確靈敏的診斷工具來進行廣泛的篩檢和公共衛生管理。

按檢測類型分類，性傳染感染 PCR 檢測組在 2024 年佔據了市場主導地位。這種主導地位主要歸因於透過多重檢測組同時準確且靈敏地檢測多種性傳播病原體，這對於全面的診斷和治療指導至關重要。

按最終用途分類，診斷實驗室領域在 2024 年佔據了最大佔有率。這是由於診斷實驗室擁有專門的基礎設施、高通量能力以及處理來自各種醫療機構的大量複雜分子診斷測試所需的專業知識。

按地區劃分，北美在性傳染感染和陰道炎 PCR 檢測市場佔據主要佔有率。這主要得益於其強大的醫療基礎設施、較高的性健康意識以及包括 PCR 檢測在內的先進診斷技術的早期採用。預計亞太地區的性傳染感染和陰道炎 PCR 檢測市場在預測期內將呈現顯著成長。這一增長的主要驅動力是醫療基礎設施的改善、可支配收入的增加以及中國和印度等國家性健康和生殖健康意識的提高。

市場的主要參與者包括 Hologic, Inc.、BD（碧迪公司）、bioMerieux、F. Hoffmann-La Roche Ltd.、賽默飛世爾科技公司、雅培實驗室、Qiagen、OraSure Technologies 和 SpeeDx Pty Ltd.。此外，一些主要參與者在較大的母公司旗下經營，例如 Cepheid（丹納赫公司）和 Luminex Corporation（DiaSorin S.p.A.）。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球STI和陰道炎的PCR檢驗市場洞察

  • 市場概述
  • STI和陰道炎的PCR檢驗市場動態
    • 促進因素和機會
      • 性傳染病和陰道炎的流行情況
      • 分子診斷技術的進步
    • 阻礙因素與課題
      • 高成本與基礎設施障礙
  • PESTEL分析
  • STI和陰道炎的PCR檢驗市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球STI和陰道炎的PCR檢驗市場:病理

  • 主要調查結果
  • 簡介
  • 性感染疾病(STI)
  • 陰道感染疾病

第6章 全球STI和陰道炎的PCR檢驗市場:檢驗類別

  • 主要調查結果
  • 簡介
  • STI PCR面板
  • 陰道炎PCR面板

第7章 全球STI和陰道炎的PCR檢驗市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院和診療所
  • 診斷檢驗室
  • 居家護理/家庭檢驗
  • 其他

第8章 全球STI和陰道炎的PCR檢驗市場:各地區

  • 主要調查結果
  • 簡介
    • STI和陰道炎的PCR檢驗市場評估:各地區，2020年～2034年
  • 北美
    • 北美:病理，2020～2034年
    • 北美:檢驗類別，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:病理，2020～2034年
    • 歐洲:檢驗類別，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:病理，2020～2034年
    • 亞太地區:檢驗類別，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:病理，2020～2034年
    • 中東·非洲:檢驗類別，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:病理，2020-2034年
    • 南美:檢驗類別，2020-2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott Laboratories
  • BD(Becton, Dickinson and Company)
  • bioMerieux
  • Cepheid(Danaher)
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Luminex Corporation(DiaSorin S.p. A.)
  • OraSure Technologies
  • Qiagen
  • SpeeDx Pty Ltd
  • Thermo Fisher Scientific Inc.
Product Code: PM5767

The global STI and vaginitis PCR testing market size is expected to reach USD 1,578.43 million by 2034, according to a new study by Polaris Market Research. The report "STI and Vaginitis PCR Testing Size, Share, Trends & Industry Analysis Report: By Condition [Sexually Transmitted Infections (STIs) and Vaginal Infections], By Test Type, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The STI and vaginitis PCR testing market focuses on the implementation of advanced diagnostics using polymerase chain reaction (PCR) technology for pathogen specific testing of STIs and different types of vaginal infections. These infections encompass common sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and trichomoniasis, alongside vaginal infections such as bacterial vaginosis and vulvovaginal candidiasis. PCR testing is unique among other testing methods due to its high sensitivity and specificity, and its ability to accurately capture the genetic material of causative organisms, no matter how minute the quantities are. This level of precision is essential for prompt and accurate diagnosis and an intense and precise treatment plan that addresses disease progression and further transmission needs.

The expectations related to this area of testing are particularly optimistic for multiple reasons. The rising prevalence of STIs and vaginitis regionally augments the demand for accurate diagnosis. The advancement in molecular diagnostic tools, as in the case of multiplex PCR assay development, is also accelerating growth in this area. The ability to detect multiple pathogens from a single sample increases both efficiency and provides enhanced diagnostic information for clinicians. Moreover, public awareness and proactive screening campaigns heighten population testing intensity, which is an encouraging trend directed toward explicitly defined sexual and reproductive health. Such changes necessitate accurate and reliable tools for diagnosis and, thereby, purposeful and strategic toward letter accessibility.

STI and Vaginitis PCR Testing Market Report Highlights:

By condition, the sexually transmitted infections (STIs) segment held a larger share in 2024, driven by the persistent high global prevalence of various STIs, many of which are asymptomatic, and the crucial need for accurate, sensitive diagnostic tools such as PCR for widespread screening and public health management.

By test type, the STI PCR panels segment dominated the market in 2024. The dominance is primarily attributed to the critical requirement for accurate and sensitive detection of a broad range of sexually transmitted pathogens, often simultaneously through multiplex panels, which are essential for comprehensive diagnosis and treatment guidance.

By end use, the diagnostic laboratories segment held the largest share in 2024, owing to their specialized infrastructure, high-throughput capabilities, and the expertise necessary for processing a large volume of complex molecular diagnostic tests from various healthcare settings.

By region, North America holds a substantial share of the STI and vaginitis PCR testing market. This is largely attributed to the robust healthcare infrastructure, high awareness regarding sexual health, and the early adoption of advanced diagnostic technologies, including PCR-based assays. The Asia Pacific STI and vaginitis PCR testing market is anticipated to exhibit a significant growth rate during the forecast period. This growth is primarily fueled by improving healthcare infrastructure, increasing disposable incomes, and a rising awareness about sexual and reproductive health in countries such as China and India.

A few key players in the market include Hologic, Inc.; BD (Becton, Dickinson and Company); bioMerieux; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Qiagen; OraSure Technologies; and SpeeDx Pty Ltd. Additionally, some key entities operate under larger parent organizations, such as Cepheid (Danaher) and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the STI and vaginitis PCR testing market report on the basis of condition, test type, end use, and region:

By Condition Outlook (Revenue - USD Million, 2020-2034)

Sexually Transmitted Infections (STIs)

Chlamydia

Gonorrhea

Trichomoniasis

Herpes Simplex Virus (HSV-1 & HSV-2)

Human Papillomavirus (HPV)

Syphilis

Other

Vaginal Infections

Bacterial Vaginosis

Vulvovaginal Candidiasis

Other

By Test Type Outlook (Revenue - USD Million, 2020-2034)

STI PCR Panels

Vaginitis PCR Panels

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Diagnostic Laboratories

Homecare/At-home Testing

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global STI and Vaginitis PCR Testing Market Insights

  • 4.1. STI and Vaginitis PCR Testing Market - Market Snapshot
  • 4.2. STI and Vaginitis PCR Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of STIs and Vaginitis
      • 4.2.1.2. Technological Advancements in Molecular Diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and infrastructure barriers
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. STI and Vaginitis PCR Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global STI and Vaginitis PCR Testing Market, by Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • 5.3. Sexually Transmitted Infections (STIs)
    • 5.3.1. Global STI and Vaginitis PCR Testing Market, by Sexually Transmitted Infections (STIs), by Region, 2020-2034 (USD Million)
    • 5.3.2. Chlamydia
    • 5.3.3. Gonorrhea
    • 5.3.4. Trichomoniasis
    • 5.3.5. Herpes Simplex Virus (HSV-1 & HSV-2)
    • 5.3.6. Human Papillomavirus (HPV)
    • 5.3.7. Syphilis
    • 5.3.8. Other
  • 5.4. Vaginal Infections
    • 5.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginal Infections, by Region, 2020-2034 (USD Million)
    • 5.4.2. Bacterial Vaginosis
    • 5.4.3. Vulvovaginal Candidiasis
    • 5.4.4. Other

6. Global STI and Vaginitis PCR Testing Market, by Test Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • 6.3. STI PCR Panels
    • 6.3.1. Global STI and Vaginitis PCR Testing Market, by STI PCR Panels, by Region, 2020-2034 (USD Million)
  • 6.4. Vaginitis PCR Panels
    • 6.4.1. Global STI and Vaginitis PCR Testing Market, by Vaginitis PCR Panels, by Region, 2020-2034 (USD Million)

7. Global STI and Vaginitis PCR Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global STI and Vaginitis PCR Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global STI and Vaginitis PCR Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 7.5. Homecare/At-home Testing
    • 7.5.1. Global STI and Vaginitis PCR Testing Market, by Homecare/At-home Testing, by Region, 2020-2034 (USD Million)
  • 7.6. Others
    • 7.6.1. Global STI and Vaginitis PCR Testing Market, by Others, by Region, 2020-2034 (USD Million)

8. Global STI and Vaginitis PCR Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. STI and Vaginitis PCR Testing Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. STI and Vaginitis PCR Testing Market - North America
    • 8.3.1. North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.3.2. North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.3.3. North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. STI and Vaginitis PCR Testing Market - U.S.
      • 8.3.4.1. U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. STI and Vaginitis PCR Testing Market - Canada
      • 8.3.5.1. Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.4. STI and Vaginitis PCR Testing Market - Europe
    • 8.4.1. Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.4.2. Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.4.3. Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. STI and Vaginitis PCR Testing Market - UK
      • 8.4.4.1. UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.4.2. UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.4.3. UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. STI and Vaginitis PCR Testing Market - France
      • 8.4.5.1. France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.5.2. France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.5.3. France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. STI and Vaginitis PCR Testing Market - Germany
      • 8.4.6.1. Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. STI and Vaginitis PCR Testing Market - Italy
      • 8.4.7.1. Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. STI and Vaginitis PCR Testing Market - Spain
      • 8.4.8.1. Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. STI and Vaginitis PCR Testing Market - Netherlands
      • 8.4.9.1. Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. STI and Vaginitis PCR Testing Market - Russia
      • 8.4.10.1. Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. STI and Vaginitis PCR Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.5. STI and Vaginitis PCR Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. STI and Vaginitis PCR Testing Market - China
      • 8.5.4.1. China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.4.2. China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.4.3. China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. STI and Vaginitis PCR Testing Market - India
      • 8.5.5.1. India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.5.2. India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.5.3. India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. STI and Vaginitis PCR Testing Market - Malaysia
      • 8.5.6.1. Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. STI and Vaginitis PCR Testing Market - Japan
      • 8.5.7.1. Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. STI and Vaginitis PCR Testing Market - Indonesia
      • 8.5.8.1. Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. STI and Vaginitis PCR Testing Market - South Korea
      • 8.5.9.1. South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. STI and Vaginitis PCR Testing Market - Australia
      • 8.5.10.1. Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. STI and Vaginitis PCR Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.6. STI and Vaginitis PCR Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. STI and Vaginitis PCR Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. STI and Vaginitis PCR Testing Market - UAE
      • 8.6.5.1. UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. STI and Vaginitis PCR Testing Market - Israel
      • 8.6.6.1. Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. STI and Vaginitis PCR Testing Market - South Africa
      • 8.6.7.1. South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. STI and Vaginitis PCR Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • 8.7. STI and Vaginitis PCR Testing Market - Latin America
    • 8.7.1. Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
    • 8.7.2. Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
    • 8.7.3. Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. STI and Vaginitis PCR Testing Market - Mexico
      • 8.7.4.1. Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. STI and Vaginitis PCR Testing Market - Brazil
      • 8.7.5.1. Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. STI and Vaginitis PCR Testing Market - Argentina
      • 8.7.6.1. Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. STI and Vaginitis PCR Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD (Becton, Dickinson and Company)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cepheid (Danaher)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Luminex Corporation (DiaSorin S.p. A.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. OraSure Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Qiagen
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. SpeeDx Pty Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 2 Global STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 3 Global STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 4 North America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 5 North America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 6 North America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 7 U.S.: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 8 U.S.: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 9 U.S.: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 10 Canada: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 11 Canada: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 12 Canada: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 14 Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 15 Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 16 UK: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 17 UK: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 18 UK: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 19 France: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 20 France: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 21 France: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 22 Germany: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 23 Germany: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 24 Germany: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Italy: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 26 Italy: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 27 Italy: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 28 Spain: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 29 Spain: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 30 Spain: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 31 Netherlands: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 32 Netherlands: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 33 Netherlands: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 34 Russia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 35 Russia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 36 Russia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 43 China: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 44 China: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 45 China: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 46 India: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 47 India: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 48 India: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Malaysia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 50 Malaysia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 51 Malaysia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 52 Japan: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 53 Japan: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 54 Japan: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Indonesia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 56 Indonesia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 57 Indonesia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 58 South Korea: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 59 South Korea: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 60 South Korea: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Australia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 62 Australia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 63 Australia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 73 UAE: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 74 UAE: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 75 UAE: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 76 Israel: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 77 Israel: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 78 Israel: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 79 South Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 80 South Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 81 South Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 86 Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 87 Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 88 Mexico: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 89 Mexico: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 90 Mexico: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Brazil: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 92 Brazil: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 93 Brazil: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 94 Argentina: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 95 Argentina: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 96 Argentina: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Condition, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: STI and Vaginitis PCR Testing Market, by Test Type, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: STI and Vaginitis PCR Testing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global STI and Vaginitis PCR Testing Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Condition
  • Figure 7. Global STI and Vaginitis PCR Testing Market, by Condition, 2024 & 2034 (USD Million)
  • Figure 8. Market by Test Type
  • Figure 9. Global STI and Vaginitis PCR Testing Market, by Test Type, 2024 & 2034 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global STI and Vaginitis PCR Testing Market, by End Use, 2024 & 2034 (USD Million)